Helius Medical Technologies Inc (NASDAQ:HSDT) has a beta value of 1.08 and has seen 3.75 million shares traded in the last trading session. The company, currently valued at $0.17M, closed the last trade at $0.33 per share which meant it gained $0.01 on the day or 1.88% during that session. The HSDT stock price is -7172.73% off its 52-week high price of $24.00 and 9.09% above the 52-week low of $0.30. If we look at the company’s 10-day average daily trading volume, we find that it stood at 31.14 million shares traded. The 3-month trading volume is 5.71 million shares.
The consensus among analysts is that Helius Medical Technologies Inc (HSDT) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 3 have rated it as a Hold, with 3 advising it as a Buy. 0 have rated the stock as Underweight.
Helius Medical Technologies Inc (NASDAQ:HSDT) trade information
Sporting 1.88% in the green in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the HSDT stock price touched $0.33 or saw a rise of 23.33%. Year-to-date, Helius Medical Technologies Inc shares have moved -97.74%, while the 5-day performance has seen it change -13.18%. Over the past 30 days, the shares of Helius Medical Technologies Inc (NASDAQ:HSDT) have changed -92.62%. Short interest in the company has seen 62031.0 shares shorted with days to cover at 1.98.
Helius Medical Technologies Inc (HSDT) estimates and forecasts
The company’s shares have lost -95.54% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 63.29% over the past 5 years.
HSDT Dividends
Helius Medical Technologies Inc is expected to release its next earnings report on 2025-May-01 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Helius Medical Technologies Inc (NASDAQ:HSDT)’s Major holders
Insiders own 17.70% of the company shares, while shares held by institutions stand at 6.31% with a share float percentage of 7.67%. Investors are also buoyed by the number of investors in a company, with Helius Medical Technologies Inc having a total of 14.0 institutions that hold shares in the company.
